Nick Simmonds is Professor of Practice (Respiratory Medicine) at the National Heart and Lung Institute (NHLI), Imperial College London and Associate Director of the Adult CF Centre at the Royal Brompton Hospital, London. His main research interests include difficult CF diagnosis and the investigation of novel CF therapies. He has been a Principal Investigator on numerous global multicentre trials and is on the Executive Committee of the European Cystic Fibrosis Society (ECFS) Clinical Trials Network. He has extensive experience of novel diagnostic techniques and is the Vice Coordinator of the ECFS Diagnostic Network. He is also on the Registry Research Committee of the UK CF Registry, a role which promotes the use of registries to better understand outcomes in CF.
et al., 2022, ECFS standards of care on CFTR-related disorders: Updated diagnostic criteria., J Cyst Fibros
et al., 2022, Mediation of the total effect of cystic fibrosis-related diabetes on mortality: A UK Cystic Fibrosis Registry cohort study, Diabetic Medicine, Vol:39, ISSN:0742-3071
et al., 2022, Clinimetric analysis of outcome measures for airway clearance in people with cystic fibrosis: a systematic review, Therapeutic Advances in Respiratory Disease, Vol:16, ISSN:1753-4666, Pages:1-12
et al., 2022, An invisible threat? Aspergillus positive cultures and co-infecting bacteria in airway sample, Journal of Cystic Fibrosis, ISSN:1569-1993
et al., 2022, Treatment Preference Among People With Cystic Fibrosis: The Importance of Reducing Treatment Burden., Chest